{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:12:03Z","timestamp":1794741123293,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The emergence of the Omicron lineage represented a major genetic drift in SARS-CoV-2 evolution. This was associated with phenotypic changes including evasion of pre-existing immunity and decreased disease severity. Continuous evolution within the Omicron lineage raised concerns of potential increased transmissibility and\/or disease severity. To address this, we evaluate the fitness and pathogenesis of contemporary Omicron variants XBB.1.5, XBB.1.16, EG.5.1, and JN.1 in the upper (URT) and lower respiratory tract (LRT). We compare in vivo infection in Syrian hamsters with infection in primary human nasal and lung epithelium cells and assess differences in transmissibility, antigenicity, and innate immune activation. Omicron variants replicate efficiently in the URT but display limited pathology in the lungs compared to previous variants and fail to replicate in human lung organoids. JN.1 is attenuated in both URT and LRT compared to other Omicron variants and fails to transmit in the male hamster model. Our data demonstrate that Omicron lineage evolution has favored increased fitness in the URT.<\/jats:p>","DOI":"10.1038\/s41467-025-55938-3","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T06:26:34Z","timestamp":1736576794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Evolution of Omicron lineage towards increased fitness in the upper respiratory tract in the absence of severe lung pathology"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5470-1505","authenticated-orcid":false,"given":"Arthur","family":"Wickenhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2173-2860","authenticated-orcid":false,"given":"Meaghan","family":"Flagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia R.","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude Kwe","family":"Yinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Goldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Gallogly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Lutterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandi N.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7758-9605","authenticated-orcid":false,"given":"Franziska","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma K.","family":"Mukesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-920X","authenticated-orcid":false,"given":"Sarah","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4368-6359","authenticated-orcid":false,"given":"Neeltje","family":"van Doremalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2113-162X","authenticated-orcid":false,"given":"Colin A.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-7758","authenticated-orcid":false,"given":"Emmie","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2288-3196","authenticated-orcid":false,"given":"Vincent J.","family":"Munster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"55938_CR1","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/v15091933","volume":"15","author":"AC Chrysostomou","year":"2023","unstructured":"Chrysostomou, A. C. et al. Unraveling the dynamics of Omicron (BA.1, BA.2, and BA.5) waves and emergence of the deltacron variant: Genomic epidemiology of the SARS-CoV-2 epidemic in cyprus (Oct 2021\u2013Oct 2022). Viruses 15, 1933 (2023).","journal-title":"Viruses"},{"key":"55938_CR2","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"55938_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"55938_CR4","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.chom.2022.07.006","volume":"30","author":"C Pastorio","year":"2022","unstructured":"Pastorio, C. et al. Determinants of Spike infectivity, processing, and neutralization in SARS-CoV-2 Omicron subvariants BA.1 and BA.2. Cell Host Microbe 30, 1255\u20131268 (2022).","journal-title":"Cell Host Microbe"},{"key":"55938_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.chom.2024.01.001","volume":"32","author":"T Tamura","year":"2024","unstructured":"Tamura, T. et al. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell Host Microbe 32, 170\u2013180 (2024).","journal-title":"Cell Host Microbe"},{"key":"55938_CR6","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect Dis. 24, e70\u2013e72 (2024).","journal-title":"Lancet Infect Dis."},{"key":"55938_CR7","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(23)00813-7","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku, Y. et al. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect. Dis. 24, e82 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"55938_CR8","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1016\/S1473-3099(23)00575-3","volume":"23","author":"K Uriu","year":"2023","unstructured":"Uriu, K. et al. Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant. Lancet Infect. Dis. 23, e460\u2013e461 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"55938_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41586-022-04441-6","volume":"603","author":"PJ Halfmann","year":"2022","unstructured":"Halfmann, P. J. et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature 603, 687\u2013692 (2022).","journal-title":"Nature"},{"key":"55938_CR10","doi-asserted-by":"publisher","unstructured":"Rosenke, K. et al. Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model. JCI Insight 7, https:\/\/doi.org\/10.1172\/jci.insight.160108 (2022).","DOI":"10.1172\/jci.insight.160108"},{"key":"55938_CR11","doi-asserted-by":"publisher","first-page":"e961","DOI":"10.1016\/S2214-109X(22)00114-0","volume":"10","author":"W Jassat","year":"2022","unstructured":"Jassat, W. et al. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study. Lancet Glob Health 10, e961\u2013e969 (2022).","journal-title":"Lancet Glob Health"},{"key":"55938_CR12","doi-asserted-by":"publisher","unstructured":"Sievers, C. et al. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022. EuroSurveillance 27, https:\/\/doi.org\/10.2807\/1560-7917.es.2022.27.22.2200396 (2022).","DOI":"10.2807\/1560-7917.es.2022.27.22.2200396"},{"key":"55938_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2276338","volume":"12","author":"M Flagg","year":"2023","unstructured":"Flagg, M. et al. Low level of tonic interferon signalling is associated with enhanced susceptibility to SARS-CoV-2 variants of concern in human lung organoids. Emerg. Microbes Infect. 12, 2276338 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"55938_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"55938_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq4450","volume":"7","author":"AZ Mykytyn","year":"2022","unstructured":"Mykytyn, A. Z. et al. Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct. Science Immunology 7, eabq4450 (2022).","journal-title":"Science Immunology"},{"key":"55938_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45274-3","volume":"15","author":"T Tamura","year":"2024","unstructured":"Tamura, T. et al. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant. Nat. Commun. 15, 1176 (2024).","journal-title":"Nat. Commun."},{"key":"55938_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls, A. C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 181, 281\u2013292 (2020).","journal-title":"Cell"},{"key":"55938_CR18","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1126\/science.abe8499","volume":"370","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science 370, 1464\u20131468 (2020).","journal-title":"Science"},{"key":"55938_CR19","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","volume":"602","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. Nature 602, 294\u2013299 (2022).","journal-title":"Nature"},{"key":"55938_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41564-021-01047-y","volume":"7","author":"JR Port","year":"2022","unstructured":"Port, J. R. et al. Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo. Nat. Microbiol. 7, 213\u2013223 (2022).","journal-title":"Nat. Microbiol."},{"key":"55938_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25156-8","volume":"12","author":"JR Port","year":"2021","unstructured":"Port, J. R. et al. SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters. Nat. Commun. 12, 4985 (2021).","journal-title":"Nat. Commun."},{"key":"55938_CR22","doi-asserted-by":"publisher","unstructured":"van Doremalen, N. et al. Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci. Transl. Med. 13, https:\/\/doi.org\/10.1126\/scitranslmed.abh0755 (2021).","DOI":"10.1126\/scitranslmed.abh0755"},{"key":"55938_CR23","doi-asserted-by":"crossref","unstructured":"Fischer, R. J. et al. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. Nat. Commun. 12, 5868 (2021).","DOI":"10.1038\/s41467-021-26178-y"},{"key":"55938_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32248-6","volume":"13","author":"N van Doremalen","year":"2022","unstructured":"van Doremalen, N. et al. ChAdOx1 nCoV-19 (AZD1222) or nCoV-19-Beta (AZD2816) protect Syrian hamsters against Beta Delta and Omicron variants. Nat. Commun. 13, 4610 (2022).","journal-title":"Nat. Commun."},{"key":"55938_CR25","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1080\/22221751.2020.1858177","volume":"9","author":"K Rosenke","year":"2020","unstructured":"Rosenke, K. et al. Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection. Emerg. Microbes Infect. 9, 2673\u20132684 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"55938_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44298-023-00012-2","volume":"2","author":"JR Port","year":"2024","unstructured":"Port, J. R. et al. Augmentation of Omicron BA.1 pathogenicity in hamsters using intratracheal inoculation. Npj Viruses 2, 3 (2024).","journal-title":"Npj Viruses"},{"key":"55938_CR27","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41596-019-0220-0","volume":"14","author":"A Jacob","year":"2019","unstructured":"Jacob, A. et al. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Nat. Protoc. 14, 3303\u20133332 (2019).","journal-title":"Nat. Protoc."},{"key":"55938_CR28","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41586-021-04352-y","volume":"602","author":"LG Thorne","year":"2022","unstructured":"Thorne, L. G. et al. Evolution of enhanced innate immune evasion by SARS-CoV-2. Nature 602, 487\u2013495 (2022).","journal-title":"Nature"},{"key":"55938_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01604-22","volume":"10","author":"D Tandel","year":"2022","unstructured":"Tandel, D. et al. SARS-CoV-2 Variant delta potently suppresses innate immune response and evades interferon-activated antiviral responses in human colon epithelial cells. Microbiol. Spectr. 10, e0160422 (2022).","journal-title":"Microbiol. Spectr."},{"key":"55938_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","volume":"603","author":"H Shuai","year":"2022","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature 603, 693\u2013699 (2022).","journal-title":"Nature"},{"key":"55938_CR31","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2023.12.025","volume":"187","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell 187, 596\u2013608 (2024).","journal-title":"Cell"},{"key":"55938_CR32","doi-asserted-by":"crossref","unstructured":"Planas, D. et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat. Commun. 15, 22574 (2024).","DOI":"10.1038\/s41467-024-46490-7"},{"key":"55938_CR33","doi-asserted-by":"publisher","first-page":"e03129","DOI":"10.1128\/mbio.03129-23","volume":"15","author":"NS Tanneti","year":"2024","unstructured":"Tanneti, N. S. et al. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. mBio 15, e03129\u201303123 (2024).","journal-title":"mBio"},{"key":"55938_CR34","doi-asserted-by":"publisher","first-page":"e1010970","DOI":"10.1371\/journal.ppat.1010970","volume":"18","author":"ACM Boon","year":"2022","unstructured":"Boon, A. C. M. et al. Reduced airborne transmission of SARS-CoV-2 BA.1 Omicron virus in Syrian hamsters. PLOS Pathog. 18, e1010970 (2022).","journal-title":"PLOS Pathog."},{"key":"55938_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114520","volume":"43","author":"P Li","year":"2024","unstructured":"Li, P. et al. Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants. Cell Rep. 43, 114520 (2024).","journal-title":"Cell Rep."},{"key":"55938_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","volume":"187","author":"P Qu","year":"2024","unstructured":"Qu, P. et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell 187, 585\u2013595 (2024).","journal-title":"Cell"},{"key":"55938_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42346-8","volume":"14","author":"JR Port","year":"2023","unstructured":"Port, J. R. et al. Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters. Nat. Commun. 14, 6592 (2023).","journal-title":"Nat. Commun."},{"key":"55938_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41564-023-01588-4","volume":"9","author":"A-K Reuschl","year":"2024","unstructured":"Reuschl, A.-K. et al. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants. Nat. Microbiol. 9, 451\u2013463 (2024).","journal-title":"Nat. Microbiol."},{"key":"55938_CR39","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.4269\/ajtmh.21-0229","volume":"104","author":"E Haddock","year":"2021","unstructured":"Haddock, E., Feldmann, F., Shupert, W. L. & Feldmann, H. Inactivation of SARS-CoV-2 laboratory specimens. Am. J. Trop. Med. Hyg. 104, 2195\u20132198 (2021).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"55938_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001091","volume":"19","author":"SJ Rihn","year":"2021","unstructured":"Rihn, S. J. et al. A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLOS Biol. 19, e3001091 (2021).","journal-title":"PLOS Biol."},{"key":"55938_CR41","doi-asserted-by":"publisher","first-page":"eabj3624","DOI":"10.1126\/science.abj3624","volume":"374","author":"A Wickenhagen","year":"2021","unstructured":"Wickenhagen, A. et al. A prenylated dsRNA sensor protects against severe COVID-19. Science 374, eabj3624 (2021).","journal-title":"Science"},{"key":"55938_CR42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","volume":"5","author":"M Letko","year":"2020","unstructured":"Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562\u2013569 (2020).","journal-title":"Nat. Microbiol."},{"key":"55938_CR43","doi-asserted-by":"crossref","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. EuroSurveillance 25, (2020).","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"55938_CR44","doi-asserted-by":"publisher","unstructured":"Speranza, E. et al. Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys. Sci. Transl. Med. 13, https:\/\/doi.org\/10.1126\/scitranslmed.abe8146 (2021).","DOI":"10.1126\/scitranslmed.abe8146"},{"key":"55938_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.1097211","volume":"305","author":"DJ Smith","year":"2004","unstructured":"Smith, D. J. et al. Mapping the antigenic and genetic evolution of Influenza Virus. Science 305, 371\u2013376 (2004).","journal-title":"Science"},{"key":"55938_CR46","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1256427","volume":"346","author":"JM Fonville","year":"2014","unstructured":"Fonville, J. M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996\u20131000 (2014).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55938-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55938-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T07:02:43Z","timestamp":1736578963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-55938-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["55938"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-55938-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.13.598902","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"594"}}